Linagliptin
Linagliptin, commonly recognised as Tradjenta, is a pharmaceutical used to manage blood sugar in chronic metabolic cases. This compound is available in 3 product options including Glyxambi and Jentadueto. These medications provide formulations designed for consistent glucose control in adults managing long-term health.
Jentadueto
Type 2 Diabetes Mellitus
2.5/500mg
Linagliptin with metformin as a film-coated tablet, used in the management of type 2 diabetes mellitus. A DPP-4 inhibitor paired with a biguanide.
Key points
- Blocks the DPP-4 enzyme, which extends the activity of incretin hormones and prompts extra insulin release after meals.
- Combination products such as Glyxambi and Jentadueto pair it with other diabetes medicines, alongside the originator brand Tradjenta.
- Existing glucose-lowering therapy needs review before starting it, since interactions between diabetes medicines are common.
What is Linagliptin?
Linagliptin acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It belongs to a class of medicines used to support metabolic health by influencing the body’s natural hormones.
This approach targets the regulation of glucose levels after meals, providing a consistent mechanism for long-term health maintenance. Because different manufacturers produce variations of this compound, patients often select specific brands based on form or combination with other active agents.
What Linagliptin is used for
This compound is primarily used to address blood glucose levels for individuals with Type 2 Diabetes. By influencing how the body produces insulin after meals, the medication works to maintain glucose levels within a desired range.
How does Linagliptin work?
The medication selectively blocks the DPP-4 enzyme. This enzyme breaks down incretin hormones, which are substances the body releases in response to food intake. By inhibiting DPP-4, the medication increases the levels of active incretin hormones. This allows the pancreas to secrete more insulin when blood sugar levels are high and reduces the amount of glucose produced by the liver.
Linagliptin brands and forms
The product range includes originator brands like Tradjenta and combination formulations such as Glyxambi and Jentadueto. Combining medicines within Diabetes Management protocols is common, and these variations exist to address specific metabolic needs. Available as a film-coated tablet, the consistent delivery format provides a reliable way to incorporate the dose into a daily routine.
Safety overview for Linagliptin
What to check before using this medicine
Individuals should review the specific product leaflet for usage guidelines and contraindications. Ensure that other existing medical conditions or concurrent medications do not conflict with this compound.
Possible reactions and tolerability
Common reactions include mild gastrointestinal discomfort or headaches. Reactions vary by individual, and sustained issues require clinical attention.
Interactions and health factors
Linagliptin may interact with other glucose-lowering agents. It is important to review interactions with any existing therapies before starting. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Further reading
Related articles
28 Jul 2026 ⋅ 10 min read
Diabetes Medicines and Weight: Which Cause Loss, Which Cause Gain
A class-by-class look at how type 2 diabetes medicines affect weight, why the same medicine does different things to different people, and what to check when your prescription follows you between countries in Asia.
Read guide